Author:
Matsunaga Yusuke,Hamada Akinobu,Okamoto Isamu,Sasaki Ji-ichiro,Moriyama Eiji,Kishi Hiroto,Matsumoto Mitsuhiro,Hira Asumi,Watanabe Hiroshi,Saito Hideyuki
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology
Reference29 articles.
1. Novel anticancer drugs in Japan.;Ogawa;J Cancer Res Clin Oncol,1999
2. Phase II study of amrubicin (SM-5887), a 9-amino-anthracycline, in previously untreated patients with extensive stage small-cell lung cancer (ES-SCLC): West Japan Lung Cancer Group Trial.;Yana;Proc Am Soc Clin Oncol,1998
3. Multidisciplinary management of lung cancer.;Spira;N Engl J Med,2004
4. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer.;Fukuoka;J Natl Cancer Inst,1991
5. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.;Noda;N Engl J Med,2002
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献